CYH
Community Health Systems Stock Falls 12% After UBS Cuts Price Target
UBS lowered its target to $2.55 from $3.00 and kept a Neutral rating, days after the company cut its full-year guidance.
Analyst ratings news
ULCC
Frontier Group Stock Rises 15% After UBS Raises Its Price Target
The same day, the airline filed an 8-K announcing a new chief operating officer and the departure of two senior vice presidents.
Freedom Capital Markets Upgrades Formfactor to Buy, Keeps $140 Target
The $140 target matches the median target among the nine firms that covered the stock in the past year.
Keefe, Bruyette & Woods Downgrades PennyMac Financial to Market Perform, Cuts Target to $80
The firm's price target falls to $80 from $100, and the median target across the seven firms covering the stock before the change is also $80.
Evercore ISI Upgrades Mohawk Industries to Outperform, Lifts Target to $171
Baird kept its neutral rating and raised its price target to $142 from $132, with both actions coming before the open.
Raymond James Downgrades Alnylam to Outperform, Cuts Target to $315
The firm lowered its price target to $315 from $420 and kept a positive stance on the stock.
Needham Downgrades Maplebear to Hold From Buy
Maplebear shares had risen 29.5% over the 20 sessions to Thursday's close of $57.11, and the firm's target is not part of the change.
BMO Capital Downgrades Honeywell Aerospace to Market Perform, Cuts Target to $181
The new $181 target compares with the prior $213 target and a coverage median of $210 before the action.
Barclays Downgrades Xylem to Equal-Weight, Cuts Target to $104; UBS Trims to $99
UBS kept its neutral rating and lowered its price target to $99 from $112 in the same session.
B of A Securities Downgrades Intel to Neutral, Cuts Target to $100
Roth Capital also downgraded Intel to neutral, with a target of $70, while Cantor Fitzgerald kept its neutral rating and cut its target to $90.
StoneX Upgrades Prosperity Bancshares to Buy; Five Other Firms Keep Ratings
Stephens & Co. raised its target to $87 from $85, and Piper Sandler cut its target to $78 from $80.
Ten Analysts Act on Boston Scientific; Jefferies Downgrades to Hold
Nine firms cut their price targets on the stock, and Baird raised its target to $51 from $50.
Twelve Analysts Raise eBay Price Targets; Wells Fargo Upgrades
Wells Fargo moved to equal-weight from underweight with a $106 target, while the other 11 firms kept their ratings.
Raymond James Upgrades ConnectOne Bancorp to Outperform, Sets $37 Target
The new target is above the $36 median of the two other firms that set price targets on the stock in the past year.
Morgan Stanley Upgrades Safehold to Equal-Weight, Cuts Target to $12
The new $12 target is below the $13 target Morgan Stanley set before the change.